Trial Comparing Metal Versus Plastic Stents for Preoperative Biliary Decompression
Launched by ADVENTHEALTH · Aug 29, 2012
Trial Information
Current as of May 29, 2025
Completed
Keywords
ClinConnect Summary
Covered self expandable metal stents (CSEMS) are three times larger in diameter than 10 Fr plastic stents. When compared to plastic stents, randomized trials have shown longer patency and fewer stent-related complications for CSEMS. The investigators hypothesize that placement of CSEMS would be a better treatment option for preoperative biliary decompression in patients with pancreatic cancer.
Gender
ALL
Eligibility criteria
- INCLUSION CRITERIA:
- • 1. Patients with pancreatic cancer and mass in the head of pancreas causing jaundice.
- • 2. Patients 19 yrs of age and older
- • 3. Serum bilirubin \> 2mg/dl
- • 4. CT: No evidence of distant metastasis or local vascular invasion (tumor surrounding portal or mesenteric vessels for more than 180 degrees of their circumference or an irregular vessel margin).
- EXCLUSION CRITERIA:
- • 1. Karnofsky score \< 60
- • 2. Prior (ERCP or PTC) attempts at biliary decompression for the same indication
- • 3. Tumor-related gastric outlet obstruction (vomiting and oral intake of \< 1L/day)
- • 4. Ongoing or planned neoadjuvant therapy
- • 5. Cholangitis at presentation or coagulopathy needing reversal medication
- • 6. Post-surgical anatomy
- • 7. Multiple extra-hepatic biliary strictures or concomitant stricture in liver hilum
- • 8. Failed ERCP's (Definition: Inability to deploy a biliary stent thereby requiring a PTC or surgery).
About Adventhealth
AdventHealth is a comprehensive, faith-based healthcare organization dedicated to providing holistic care and advancing medical research through innovative clinical trials. With a commitment to improving patient outcomes and enhancing the quality of life, AdventHealth integrates cutting-edge technology and compassionate care across its extensive network of hospitals and outpatient facilities. The organization emphasizes a patient-centered approach, fostering collaboration among multidisciplinary teams to explore new treatment options and therapies. By participating in clinical research, AdventHealth aims to contribute to the advancement of medical knowledge and deliver transformative healthcare solutions to communities it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Orlando, Florida, United States
Patients applied
Trial Officials
shyam varadarajulu, MD
Principal Investigator
Florida Hospital Center for Interventional Endoscopy
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials